We are delighted to announce that we are showcased as one of the 50 companies in PwC UK’s ‘Life Sciences Future 50’ report.
The report illustrates the world-class science and innovation being led by the UK’s life sciences sector to solve some of the most important challenges in scientific research and human healthcare.
The Future50 sample is the result of a rigorous research process starting with the identification of 500+ UK-based innovative life sciences companies with the potential to deliver breakthrough solutions.
Selection was based upon:
- Impact potential: the problem the company is trying to solve,
- Breakthrough science and innovation: what they are doing to solve it,
- Differentiation: how they are doing it,
- Maturity: where they are on their journey.
Find out more in the full report here.
See p35 for CN Bio.